{"id":18226,"date":"2026-04-01T13:42:38","date_gmt":"2026-04-01T13:42:38","guid":{"rendered":"https:\/\/www.colorectalcancercanada.com\/?post_type=drug&#038;p=18226"},"modified":"2026-04-08T16:03:59","modified_gmt":"2026-04-08T16:03:59","slug":"bevacizumab","status":"publish","type":"drug","link":"https:\/\/www.colorectalcancercanada.com\/fr\/drug\/bevacizumab\/","title":{"rendered":"Bevacizumab"},"content":{"rendered":"<p><strong>Indication :<\/strong><\/p>\n<p>Traitement de premi\u00e8re intention du cancer colorectal m\u00e9tastatique (CCRm) chez les patients atteints d&rsquo;un cancer m\u00e9tastatique du c\u00f4lon ou du rectum. Il est utilis\u00e9 en association avec une chimioth\u00e9rapie \u00e0 base de fluoropyrimidine dans le cadre d&rsquo;un traitement syst\u00e9mique initial.<\/p>\n<p>Les patients peuvent \u00e9galement recevoir du bevacizumab sous forme de biosimilaires, notamment MVasi (Amgen), Zirabev (Pfizer) et Alymsys (JAMP Pharma).<\/p>\n","protected":false},"template":"","crc_subtype":[401],"drug_stage":[402],"therapy_line":[418],"health_canada_approval":[404],"cda_review":[],"cda_recommendation":[],"inesss_review":[],"inesss_recommendation":[],"pcpa_status":[],"public_reimbursement":[411,410,454,450,451,414,457,453,413,412,452,456,455],"class_list":["post-18226","drug","type-drug","status-publish","hentry","crc_subtype-none-fr","drug_stage-iv-fr","therapy_line-premiere-ligne","health_canada_approval-approved-fr","public_reimbursement-alberta-fr","public_reimbursement-colombie-britannique-fr","public_reimbursement-i-p-e","public_reimbursement-manitoba-fr","public_reimbursement-n-b","public_reimbursement-ns-fr","public_reimbursement-nt","public_reimbursement-on","public_reimbursement-qc-fr","public_reimbursement-sk-fr","public_reimbursement-t-n-l","public_reimbursement-t-n-o","public_reimbursement-yn"],"_links":{"self":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/drug\/18226","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/drug"}],"about":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/types\/drug"}],"wp:attachment":[{"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/media?parent=18226"}],"wp:term":[{"taxonomy":"crc_subtype","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/crc_subtype?post=18226"},{"taxonomy":"drug_stage","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/drug_stage?post=18226"},{"taxonomy":"therapy_line","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/therapy_line?post=18226"},{"taxonomy":"health_canada_approval","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/health_canada_approval?post=18226"},{"taxonomy":"cda_review","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/cda_review?post=18226"},{"taxonomy":"cda_recommendation","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/cda_recommendation?post=18226"},{"taxonomy":"inesss_review","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/inesss_review?post=18226"},{"taxonomy":"inesss_recommendation","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/inesss_recommendation?post=18226"},{"taxonomy":"pcpa_status","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/pcpa_status?post=18226"},{"taxonomy":"public_reimbursement","embeddable":true,"href":"https:\/\/www.colorectalcancercanada.com\/fr\/wp-json\/wp\/v2\/public_reimbursement?post=18226"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}